Product Information
OFLOXACIN 0.3% EAR DROPS is a generic product labeled by Caplin Steriles Limited, priced at $1.1098 per ML under NDC 65145014301. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Jan 5, 2024. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Ofloxacin Otic market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/mL
Manufacturer
Caplin Steriles LimitedNDC
65145014301
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217903FDA Approved
1/5/2024
TE Code
AT
On Market Since
12/16/2024
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EAR DROPS has been published 52 times since Oct 8, 2025, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1098 per ML |
|---|---|
| All-time high | $1.3628 (Oct 15, 2025) |
| All-time low | $1.0722 (Jul 22, 2026) |
| 52-week high | $1.3628 |
| 52-week low | $1.0722 |
| Median price | $1.1716 |
| Average price | $1.1945 |
| Largest weekly change | -4.2% (Jul 22, 2026) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ofloxacin Otic market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Caplin Steriles Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ofloxacin Otic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EAR DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EAR DROPS, manufactured by Caplin Steriles Limited, is $1.1098 per ML (NDC 65145014301), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EAR DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EAR DROPS has declined 18.6%. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EAR DROPS?
Since Oct 8, 2025, the NADAC for OFLOXACIN 0.3% EAR DROPS has ranged from a low of $1.0722 (Jul 22, 2026) to a high of $1.3628 (Oct 15, 2025), with a median of $1.1716 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EAR DROPS?
No other NADAC-published product currently shares the active ingredient and strength of OFLOXACIN 0.3% EAR DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OFLOXACIN 0.3% EAR DROPS?
OFLOXACIN 0.3% EAR DROPS (NDC 65145014301) is labeled by Caplin Steriles Limited, and CMS classifies it as a generic product.